The Diagnostic Is Well Known. The System Is Still Incomplete
The Diagnostic Is Well Known. The System Is Still Incomplete
European tech transfer has been debated for over two decades. The bottlenecks are identified. The system is still incomplete.
Christophe Haunold has been inside that system for 30 years. He built and led one of France's regional tech transfer companies, served as president of ASTP, and created the central tech transfer office at the University of Luxembourg. What follows draws entirely from our recent conversation.
The Question That Opens the Door
Christophe does not open with the word commercialization. He asks something more basic: would you like your scientific results to become useful to someone?
Nobody answers no.
Public researchers chose their careers for intellectual freedom and time to make mistakes. Once the answer is yes, the conversation about pathways (company creation, licensing, industry collaboration) can happen on the researcher's terms.
The Fantasy of the Researcher-Entrepreneur
One assumption persists in European innovation policy: every researcher should become a businessman. Christophe called it a nightmare. The goal is to provide the right environment for those with the ambition, not push everyone toward entrepreneurship.
The TTO: Compliance Office or Strategic Tool
Three points stood out. Alignment: IP is only a tool, and a TTO is only a tool. Resources: most TTOs consider themselves too small, and a complete team needs competencies across IP, legal, science, and finance. Differentiation: a large technological university requires a different approach than a small humanities university.
The structural answer is mutualization. In France, one tech transfer company per region served multiple universities. The pipeline became large enough to build a complete team and develop real expertise.
IP Strategy and the University Equity Debate
Christophe's position: five to ten percent initial equity is an acceptable range. The principle he advocates is speed. With sufficient volume, you offer a ready-to-use process and stop negotiating over uncertainty. The worst situation is founders fighting the university from the start. They are on the same side of the table. The university's main objective is impact, not IP revenue.
What Stays With Me
After 15 or 20 years, the system is still incomplete. Christophe's approach: sit on the same side of the table as the researcher, and find conditions acceptable to investors, to the company, and to the university. Because the main objective of a university is not to make money with IP. It is to create impact.
Timecode:
00:00 Meet Christophe Haunold02:30 From Chemical Engineering to Knowledge Transfer06:04 Europe's Innovation Landscape and ASTP11:38 Motivating Researchers to Commercialize19:24 Building Teams and Attracting Business Talent23:22 Capital Gaps and TTO Decisions31:28 Why University IP Goes Unused35:15 Investment Readiness and Licensing Strategy40:45 University Equity and Fast Track Frameworks48:05 Shared TTO Models, Deep Tech, and Closing Thoughts
Links:
Károly Szántó : https://www.karolyszanto.com/ [https://www.karolyszanto.com/]
UniVCC : https://univccoalition.org/ [https://univccoalition.org/]
Guest:
Christophe Haunold: https://www.linkedin.com/in/christophe-haunold/